Neurology News

In a cohort of Japanese men and women, higher peanut consumption decreased risk for total and ischemic stroke, as well as CVD, but not ischemic heart disease, according to results of the Japan Public Health Center study.

NIH’s National Institute on Aging announced a $55.6 million grant for Alzheimer’s disease research conducted by the University of Washington, Kaiser Permanente Washington and the University of California San Diego.

The FDA has approved an expanded indication for Briviact CV tablets, oral solution and injection, for treating partial-onset seizures among children as young as 1 month.

HHS recently announced a plan supporting legislation that would allow it to negotiate Medicare Part B and Part D drug prices directly with pharmaceutical companies and then make those prices available to other purchasers.

The National Institute on Aging, a division of the NIH, has granted $15.1 million to Roberta Diaz Brinton, PhD, to aid her research on the increased risk for Alzheimer’s disease in women, according to a press release.

Cannabidiol transdermal gel improved outcomes among children with developmental and epileptic encephalopathies, according to results of a nonrandomized controlled trial published in JAMA Network Open.

Depression appeared to increase risk for incident vascular disease and mortality among individuals with MS, according to results of a population-based retrospective matched cohort study published in Neurology.

It is estimated that the pharmaceutical industry spent more than $24 billion on prescription drug promotion in 2017.

For many physician investors, the present bull run in the U.S. stock market – the longest in its history – has led to long-term concerns about how the markets will fare in the next decade or two.

Continuous administration of ocrelizumab in clinical trials and its broader use in real-world settings exhibited a favorable and manageable safety profile for relapsing MS and primary progressive MS, according to a study in Neurology.